| UHC Surest Medical and Drug | Collagen Crosslinks and Biochemical Markers of Bone Turnover - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Complement Inhibitors - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Cosmetic and Reconstructive Procedures - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Cytological Examination of Breast Fluids for Cancer Screening or Diagnosis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Denosumab - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Diagnostic Dynamic Spinal Visualization and Vertebral Motion Analysis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Discogenic Pain Treatment - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Elective Inpatient Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Electric Tumor Treatment Field Therapy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |